| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 126,507 | 87,039 | 86,268 | 121,690 | | Cost of Revenue | 67,785 | 50,313 | 51,589 | 74,961 | | | Gross Profit | 58,722 | 36,726 | 34,679 | 46,729 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 37,306 | 29,585 | 29,703 | 26,914 | | Non Recurring | (549) | 549 |
-
| 273,034 | | Others | 153 | 165 | 196 | 219 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 21,812 | 6,427 | 4,780 | (253,438) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 464 | (96) | (638) | 5,303 | | Earnings Before Interest And Taxes | 22,276 | 6,331 | 4,142 | (248,135) | | Interest Expense | 819 | 972 | 1,177 | 3,531 | | Income Before Tax | 21,457 | 5,359 | 2,965 | (251,666) | | Income Tax Expense | 7,864 | 2,030 | 1,177 | (39,217) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 13,593 | 3,329 | 1,788 | (212,449) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 13,593 | 3,329 | 1,788 | (212,449) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $13,593 | $3,329 | $1,788 | ($212,449) |
|
0.01% Nasdaq 
Income Statement
